baber/WOPTO huggingface dataset:
Patent AU-689606-B2 (AU)
Title: Printable release compositions for adhesive articles
Inventor: SHIPSTON ADELE C
IPC: C09J7/40
Filed: 1995-01-20
Granted: 1998-04-02
Abstract: The invention relates to a composition for use as a release for a repositionable adhesive comprising:     (a) about 10 to about 80 parts by wet weight of a surfactant; and (b) about 20 to about 90 parts by wet weight of an acrylic copolymer.     Preferably the release layer comprises:     (a) about 20 to about 60 parts by weight surfactant; and (b) about 40 to about 80 parts by weight acrylic copolymer. The invention extends to an article comprising a substrate and a release layer comprising the above composition coated onto at least a portion of one side of the substrate.
Patent AU-664214-B2 (AU)
Title: Drug delivery device
Inventor: CORISH JOHN
IPC: A61N1/30
Filed: 1992-11-10
Granted: 1995-11-09
Abstract: PCT No. PCT/IE92/00021 Sec. 371 Date May 13, 1994 Sec. 102(e) Date May 13, 1994 PCT Filed Nov. 10, 1992 PCT Pub. No. WO93/09842 PCT Pub. Date May 27, 1993.A transdermal device for the controlled administration of a drug to the skin comprises a reservoir (12) for the drug and an electric circuit which includes an electrode system (13, 14) which is operable to actively transport the drug in a controlled manner from the reservoir (12) towards the skin for transport therethrough, the skin not being part of the electric circuit, and the drug passing through an electrode (13) of said electrode system (13, 14) during the active transport to the skin. The electrode (13) is disposed between the reservoir (12) for the drug and an optional transit chamber (15). The electrode (13) can be permeable to the drug or the electrode can function as a gate, being permeable to the drug in the open condition and less permeable to the drug in the closed condition. The operation of the gate can be determined by the composition or the structure of the electrode (13). The device achieves drug delivery rates comparable to those achieved with iontophoretic devices.
Patent AU-650803-B2 (AU)
Title: Integrated pulping process of waste paper yielding tissue-grade paper fibers
Inventor: HANKINS CHARLES W
IPC: D21C9/10
Filed: 1992-11-25
Granted: 1994-06-30
Abstract: This invention provides an integrated system for recovering fibers from mixed grades of waste paper and simultaneously cleaning (deinking) waste fibers. The system comprises a mild alkaline pulping process with oxygen and hydrogen peroxide followed by rapid decompression of fibers and then by hot washing. <IMAGE>
Patent AU-612781-B2 (AU)
Title: Fat-containing compositions having a low phosphatide content
Inventor: GROOTSCHOLTEN PAULUS ADRIANUS
IPC: A23D7/00
Filed: 1989-02-06
Granted: 1991-07-18
Abstract: A frying fat having improved anti-spattering behaviour due to the presence of a specific phosphatide composition, which phosphatide composition, however, induces only very limited browning on frying. The phosphatide composition is added at a very low concentration level of about 0.01 wt.%. The phosphatide composition used is enriched in PC and PI, at the cost of PE and sugars.
Patent AU-784739-B2 (AU)
Title: Process for the preparation of a vegetable yogurt
Inventor: ZUCCATO REMO
IPC: A23L19/00
Filed: 2001-03-22
Granted: 2006-06-08
Abstract: The process allows the production of a vegetable yogurt formed by fermentation of vegetable products such as green vegetables and fruits under the action of lactic bacteria. The fermentation involves a first phase of preparation of the vegetable substrate, during which the green vegetables and/or fruit are ground, then water is added to obtain a creamy or liquid product. Then pasteurization is carried out. Afterwards the cultures of lactic bacteria are inoculated whereby the fermentation step is carried out at a variable temperature depending on the strain being used. After the pH reaches a value of about 3.8-4.5 fragrances and/or thickening agents, fruit puree, or fruit in small pieces or cereals are added and subsequently the product is packaged. The product made by the process of this application is part of the invention.
Patent AU-759227-B2 (AU)
Title: Data handling system
Inventor: EALES MICHAEL DAVID
IPC: H04Q3/00
Filed: 2001-02-08
Granted: 2003-04-10
Abstract: In order to store data in a mobile telecommunications system, a data storage unit (HLR) has data functions (72,74) providing data redundancy therebetween, control functions (79,80) and signalling point (30,31,32) to enable the data storage unit to pass data to and from a mobile telecommunications network under the control of the control function. The control functions are physically separate from the data functions. The data functions (72,74) may operate on the basis that one has a primary data function, a second has a primary standby function to achieve synchronised updating. The use of separate and hence distributed functions enables greater flexibility in the retrieval of data from the data storage unit (HLR)
Patent AU-697343-B2 (AU)
Title: A liposomal delivery system for biologically active agents
Inventor: THIERRY ALAIN R
IPC: C12N15/88
Filed: 1995-08-04
Granted: 1998-10-01
Abstract: PCT No. PCT/US95/09867 Sec. 371 Date Jan. 29, 1996 Sec. 102(e) Date Jan. 29, 1996 PCT Filed Aug. 4, 1995The present invention is directed to a liposomal preparation which is based on specific lipid components. The liposomal compounds are also combined with a biologically active agent, forming liposomal compounds. These compounds are useful in drug delivery, where specific therapeutic compounds are provided in the liposomes. The specific lipid components of the present invention provide a highly efficient and stable delivery system for nucleic acids. Consequently, one embodiment of the invention provide the liposomal preparations which are suitable for use in gene therapy.
Patent AU-566849-B2 (AU)
Title: Membrane-associated protein
Inventor: BOHN HANS
IPC: C07K14/435
Filed: 1984-09-21
Granted: 1987-10-29
Abstract: Membrane-associated proteins, called MP2, and a process for obtaining them are described. The proteins have the following parameters: (a) an electrophoretic mobility in the range between that of  alpha 2 and that of  beta 1 globulins; (b) an isoelectric point in the pH range 4.4-5.0; (c) a sedimentation coefficient s20Wc in the range from 7 to above 20 S, the main fractions (IV, III, II and I) sedimenting at about 7, 9, 14 and 20 S respectively; (d) molecular weights in the range from 200,000 to 1,000,000, the main fractions (IV, III, II and I) having molecular weights of about 210,000, 400,000, 750,000 and 1,000,000; (e) an extinction coefficient E1 cm1% (280 nm) of 12.5+/-0.2; (f) a carbohydrate content of 8.0+/-3.2% (mannose 1.4+/-0.4%, fucose 0.4+/-0.2%, galactose 1.2+/-0.4%, N-acetylglucosamine 2.6+/-1.8%, and N-acetylneuraminic acid 2.4+/-1.4%) and (g) aminoacid composition in which aspartic acid, glutamic acid, leucine, valine, serine and glycine are among the aminoacids present in greatest amounts. These proteins can be used to prepare antisera which can be used to detect and determine these proteins or their components. Furthermore, antibodies reacting with these proteins can be used for diagnosis, monitoring the progress of a disease or checking therapy.
Patent AU-724212-B2 (AU)
Title: Down-regulation of DNA repair to enhance sensitivity to P53-mediated suppression
Inventor: GJERSET RUTH A
IPC: A61K31/203
Filed: 1997-07-02
Granted: 2000-09-14
Abstract: The present invention details methods for the treatment of cancer. In particular, it concerns the induction of apoptosis in cancer cells following treatment with inhibitors of DNA repair in combination with p53 gene therapy. Treatment of glioblastoma and breast tumor cells with inhibitors of DNA repair induced growth suppression that was a result of p53-mediated apoptosis. Thus it appears that inhibitors of DNA repair in combination with p53 gene therapy is involved in restoration of p53-mediated apoptosis.
Patent AU-637319-B2 (AU)
Title: Gas-phase fluorination process
IPC: C07C17/087
Filed: 1989-05-23
Granted: 1993-05-27
Abstract: An improved gas-phase process for the manufacture of 1,1,1-trifluorodichloroethane and/or 1,1,1,2-tetrafluorochloroethane by contacting a suitable tetrahaloethylene with hydrogen fluoride in the presence of a selected metal in combination with a high fluorine content aluminum-containing compound, the reaction being conducted under controlled conditions whereby the production of pentafluoroethane is minimized.
Patent AU-662406-B2 (AU)
Title: Communication system with call charge information stored in handset
Inventor: WARWICK GERALD ANTHONY
IPC: H04M15/00
Filed: 1993-03-18
Granted: 1995-08-31
Abstract: A communication system, such as a portable telephone telepoint system, comprises a handset 11 and a base station 10, the handset can receive a registration sequence from the base station and store a number dependent thereon. The base station meters charge units and generates a new registration sequence when a unit is to be charged and transmits the new sequence to the handset. A new number stored in the handset and dependent on the new sequence differs from the old number to reflect deduction of pre-paid charge units. The handset may display remaining credit information. A voice prompt may warn that credit is running low. <IMAGE>
Patent AU-748996-B2 (AU)
Title: A capsule based drug delivery system
Inventor: BROWN MALCOLM DAVID
IPC: A61K47/38
Filed: 1999-11-04
Granted: 2002-06-13
Abstract: A soft capsule comprising a wall derived from a multilayer film that comprises three layers. The layers are an innermost sealing plasticized hydroxypropyl methyl cellulose, an adhesion promoting layer of propylene glycol alginate and a barrier layer of sodium alginate.
Patent AU-670785-B2 (AU)
Title: Container and closure
Inventor: SEYMOUR RICHARD WILLIAM
IPC: B65D41/17
Filed: 1993-04-06
Granted: 1996-08-01
Abstract: PCT No. PCT/GB93/00724 Sec. 371 Date Oct. 6, 1994 Sec. 102(e) Date Oct. 6, 1994 PCT Filed Apr. 6, 1993 PCT Pub. No. WO93/21079 PCT Pub. Date Oct. 28, 1993A container and closure combination wherein the closure comprises a skirt portion, the periphery of which has at least one rounded ramped portion adapted to cooperate with one or more corresponding rounded ramped portions on the container such that relative axial rotation of the container causes cooperation of the ramped portions and disengagement of the closure from the container.
Patent AU-663592-B2 (AU)
Title: Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals
Inventor: ENHSEN ALFONS
IPC: A61P7/00
Filed: 1993-06-11
Granted: 1995-10-12
Abstract: Bile acid derivatives of the formula I  Z(X-GS)n in which GS, X, Z and n have the stated meanings, and a process for the production of these compounds are described. The compounds have pharmacological activity and can therefore be used as pharmaceuticals, in particular as hypolipidaemic.
Patent AU-760749-B2 (AU)
Title: Powder inhaler for combined medicament
Inventor: HAIKARAINEN JUSSI
IPC: A61M15/00
Filed: 2000-04-20
Granted: 2003-05-22
Abstract: The invention relates to a multidose powder inhaler for the dispensing of a powdered medicament by inhalation. The device comprises two or more medicament containers for different drug powders which are inhaled as a combined medication, and separate aerosolization channels for each drug powder. The device of the invention is useful, for example, in the treatment of asthma.
Patent AU-773821-B2 (AU)
Title: Treatment agent for hydrophilicity and method for preparing thereof
Inventor: MATSUKAWA MASAHIKO
IPC: C09D7/62
Filed: 2001-05-11
Granted: 2004-06-10
Abstract: A treatment agent for hydrophilicity preferable for aluminum materials used for heat exchanger parts and air filter parts of air cleaner which can maintain the deodorizing property and hydrohilicity even after a long-time use, and a method of preparing said treatment agent. A treatment agent for hydrophilicity according to this invention comprising silica particulates and polymer of vinyl alcohol series in the weight ratio in the range 30:70 SIMILAR 70:30, amounting to 0.2 SIMILAR 25 weight percent in total of both relative to the entire treatment agent, in which said silica particulates are coated with said polymer of vinyl alcohol series, and dispersed in aqueous medium as coated particles having the average particle diameter 5 SIMILAR 1000 nm.
Patent AU-703688-B2 (AU)
Title: Process for producing 3,5-diaryl pyrazolene
Inventor: MERKLE HANS RUPERT
IPC: C07D231/12
Filed: 1996-01-04
Granted: 1999-04-01
Abstract: PCT No. PCT/EP96/00011 Sec. 371 Date Jul. 3, 1997 Sec. 102(e) Date Jul. 3, 1997 PCT Filed Jan. 4, 1996 PCT Pub. No. WO96/21650 PCT Pub. Date Jul. 18, 1996A process for preparing 3,5-diarylpyrazoles of the general formula I    <IMAGE>  I  where the substituents have the following meanings: R1 and R3 are unsubstituted or substituted aryl radicals, R2 is hydrogen, C1-C8-alkyl or unsubstituted or substituted aryl, in which hydrazine hydrate is reacted with a 1,3-diarylpropenone of the general formula II    <IMAGE>  II  where the substituents R1, R2 and R3 have the abovementioned meanings, in sulfuric acid in the presence of iodine or an iodine compound, is described.
Patent AU-655123-B2 (AU)
Title: Alkyl (oxo-benzoxazinyl)-amino and alkyl (oxo-pyridoxazinyl)-amino alkanoates
Inventor: GUACIARO MICHAEL ANTHONY
IPC: C07F7/08
Filed: 1993-08-23
Granted: 1994-12-01
Abstract: 2-(1-Substituted-2-imidazolin-2-yl)benzoic and nicotinic acids, and derivatives thereof, which are effective in the control of undesirable plant species are described. Also described are a method for the herbicidal use of the compounds and a method for their preparation.
Patent AU-673847-B2 (AU)
Title: Transformation of phaffia rhodozyma
Inventor: OOYEN ALBERT JOHANNES JOSEPH V
IPC: C12P21/02
Filed: 1993-09-10
Granted: 1996-11-28
Abstract: The present invention discloses a transformed Phaffia strain. Also disclosed are specific vectors for transforming Phaffia, preferably such vectors contain expression regulating sequences obtained from Phaffia. The present invention also discloses the use of certain marker genes in Phaffia. The invention further discloses a method for transforming Phaffia.
Patent AU-728455-B2 (AU)
Title: Preparation of 3-fluoro oxindole derivatives
Inventor: PENDRI YADAGIRI R
IPC: C07D209/34
Filed: 1997-10-07
Granted: 2001-01-11
Abstract: The present invention relates to novel itermediates of formula (1) wherein the wavy bond ( SIMILAR   SIMILAR ) represents the racemate, the (R)-enantiomer or the (S)-enantiomer; and R is hydrogen, a carboxyl-protecting group or a cation of an addition salt; or solvate thereof; and to the use thereof in a process for the preparation of certain 3-fluoro oxindole derivatives.
Patent AU-664114-B2 (AU)
Title: Spray-stable aqueous foam, its production and use
Inventor: HELBER RUDOLF
IPC: C14C11/00
Filed: 1993-09-15
Granted: 1995-11-02
Abstract: Aqueous spray-resistant and pourable foams (S), produced by mechanical foaming of corresponding aqueous compositions (W), wherein the aqueous phase contains(A) a curable polymer system, which consists of(U) an ionomeric polyurethane or a mixture of ionomeric polyurethanes and optionally(P) one or more further polymers curable at least together with (U),and (B) at least one foam-stabilizerand the liter-weight of (S) at 20° C. and normal pressure is in the range of 400 to 700 g,are eminently suitable for foam-coating of corresponding substrates, in particular of leather.
Patent AU-751146-B2 (AU)
Title: Cyclic peptides that bind to urokinase-type plasminogen activator receptor
Inventor: JONES TERENCE R
IPC: C07K7/54
Filed: 1997-10-21
Granted: 2002-08-08
Abstract: Cyclic peptide compounds having 11 amino acids joined by a linking unit L, such that the linear dimension between the Calpha carbon of the first amino acid and the Calpha carbon of eleventh amino acid is between about 4 and 12 Ångstrom units; are useful for inhibiting the binding of uPA to the uPAR receptor. Methods for using the cyclic peptide compounds, and compositions containing them, for inhibiting the growth or metastasis of cancerous tumors are also disclosed.
Patent AU-630044-B2 (AU)
Title: Chassis frame for a wheeled motor vehicle
Inventor: TOWNSEND JOHN A
IPC: B62D25/20
Filed: 1990-01-25
Granted: 1992-10-15
Abstract: A chassis frame is provided with a reinforced floor section and barrier sections fixed to the floor section in longitudinally spaced relationship to one another. Door openings are formed between the barrier sections to either side of the frame. The floor section is of a reduced width and the barrier sections include outwardly convex curvilinear side portions extending laterally relative to the floor section. Door panels are carried by the side portions for slidable movement relative thereto in a curvilinear path defined by the shape of the side portions between extended positions bridging the door openings and retracted positions stowed beneath the floor section. The door panels are tension, compression and torsion resistant and, when in the extended positions, mutually engage the floor section and the sides of the door openings to impart rigidity to the frame.
Patent AU-698052-B2 (AU)
Title: Inline solid state polymerization of PET flakes for manufacturing plastic strap
Inventor: ERDEN DONALD L VAN
IPC: C08J11/04
Filed: 1998-01-21
Granted: 1998-10-22
Abstract: The present invention is a process of making strap using both post consumer and non-post consumer PET of wide distribution intrinsic viscosity (IV) through direct solid state polymerization in a non-peletized state to produce PET with an increased, heterogenous IV suitable for high performance strap extrusion. The process increases the IV of post-consumer resins, consisting principally of polyethylene terephthalate (PET), by preferably chopping the post-consumer plastic into flakes and chunks, rolling the flakes and chunks, preheating the flakes, and further heating the pre-heated flakes and chunks in an atmosphere of hot nitrogen gas, thereby increasing their intrinsic viscosity. PET polymers having increased viscosities provide a polymer useful in manufacturing a high performance strap material.
Patent AU-680644-B2 (AU)
Title: A heat engine and heat pump
Inventor: CONEY MICHAEL WILLOUGHBY ESSEX
IPC: F02G1/00
Filed: 1993-12-01
Granted: 1997-08-07
Abstract: PCT No. PCT/GB93/02472 Sec. 371 Date Jun. 1, 1995 Sec. 102(e) Date Jun. 1, 1995 PCT Filed Dec. 1, 1993 PCT Pub. No. WO94/12785 PCT Pub. Date Jun. 9, 1994An internal combustion engine has a compression cylinder with a liquid spray apparatus for spraying sufficient liquid into the cylinder such that the liquid absorbs the heat of the gas as it is compressed without vaporizing. A separator removes the liquid from the gas/liquid mixture as it leaves the cylinder. The gas is then directed to a expansion cylinder for combustion with fuel delivered by a fuel supply apparatus. The cylinders being coupled together by a crankshaft.
Patent AU-759518-B2 (AU)
Title: System and method for resolving frequency and timing uncertainty in access channel acquisition in a spread spectrum communication system
Inventor: CHOCKALINGAM ANANTHANARAYANAN
IPC: H04L7/00
Filed: 1999-08-27
Granted: 2003-04-17
Abstract: A method for reducing the number of required frequency and time hypotheses to acquire an access transmission in a satellite communication system. By reducing the number of required hypotheses, the amount of hardware required to acquire the access transmission is reduced. The method of the present invention reduces the number of required hypotheses by reducing the range of possible frequency and timing values of the access transmission. The range of possible frequency and timing values is reduced by determining the frequency and time uncertainties over individual satellite beams rather than over an entire satellite footprint.
Patent AU-588629-B2 (AU)
Title: Medicaments to combat chronic graft-versus-host diseases and to combat autoimmune diseases, in particular systemic lupus erythematosus
Inventor: BARTLETT ROBERT R
IPC: C07C255/23
Filed: 1986-09-26
Granted: 1989-09-21
Abstract: The medicaments are prepared from compound 1 and/or 2 of the formulae 
<IMAGE>
 or salts of compound 2, in dosage units.
Patent AU-635358-B2 (AU)
Title: Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
IPC: A61K31/425
Filed: 1990-11-09
Granted: 1993-03-18
Abstract: The invention relates to the transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole or the (-)-enantiomer thereof and transdermal systems containing these active substances.
Patent AU-549890-B2 (AU)
Title: Para-substituted-3-phenoxy-1-alkoxycarbenyl-alkylamino- propanol-2 compounds
Inventor: CARLSSON ENAR INGEMAR
IPC: C07C227/14
Filed: 1981-05-29
Granted: 1986-02-20
Abstract: The present invention relates to new compounds of the formula I <IMAGE> (I)  as well as their preparation, pharmaceutical preparations containing same, and method of treating acute myocardial infarction. The compounds which possess beta-adrenoceptor blocking activity are very shortacting and are preferably intended for treatment of acute myocardial infarction by administration by means of injection.
Patent AU-715079-B2 (AU)
Title: Lighter
Inventor: ROGELET THIERRY
IPC: F23Q2/28
Filed: 1996-10-03
Granted: 2000-01-13
Abstract: PCT No. PCT/IB96/01139 Sec. 371 Date May 15, 1998 Sec. 102(e) Date May 15, 1998 PCT Filed Oct. 3, 1996 PCT Pub. No. WO97/27431 PCT Pub. Date Jul. 31, 1997A lighter actuated by a push-control member (24) which can move in a longitudinal direction, and which resists use by children, comprising a lighter-body (2) and lighting means comprising said push-control member. The push-control member (24) is guided in two essentially perpendicular directions, a longitudinal direction (36) in relation to the lighter body (2) and a transverse direction (38, 56, 60) in relation to the lighter body (2). The push-control member (24) has an abutment face (34, 46, 52, 53) which is normally opposite a counter-abutment surface (34, 44, 2) integral with the lighter-body (2), and the push-control member (24) is displaceable in the transverse direction (38, 56, 60) such that its abutment face is then in a non-active position relative to its counter-abutment surface. Elastic means (40, 54, 58, 41, 62) comprising an elastic tongue member extending longitudinally and deformable transversely in accordance with transverse movement of the push-control member (24), act in a transverse direction (38, 56, 60) to return the abutment face of the push-control member to a position opposite the counter-abutment surface, means being provided to return the push-control member (24) into a position of rest in the longitudinal direction. Said elastic means may comprise a U-shaped metallic strip, one branch of which being elastically deformable, the second branch acting as an electrode forming electrical contact with the conductive material of a piezoelectric lighting system.
Patent AU-740598-B2 (AU)
Title: Aplidine as an L-type calcium channel enhancer
Inventor: CRUMB WILLIAM J
IPC: A61K38/08
Filed: 1998-05-06
Granted: 2001-11-08
Abstract: This invention relates to a new use discovered for the compound known as Aplidine (dehydrodidemnin B) which has the following structure: Aplidine has been found to be a potent L-type calcium channel enhancer in the human heart. This effect makes Aplidine a very useful drug for the treatment of congestive heart failure, as well as useful for the treatment of atrial fibrillation.
Patent AU-598543-B2 (AU)
Title: An insulin preparation for non-parenteral administration
Inventor: BALSCHMIDT PER
IPC: A61K38/28
Filed: 1987-04-14
Granted: 1990-06-28
Abstract: PCT No. PCT/DK87/00038 Sec. 371 Date Dec. 14, 1987 Sec. 102(e) Date Dec. 14, 1987 PCT Filed Apr. 14, 1987.Insulin preparations for non-parenteral administration and containing one or more insulins or insuling derivatives, which in solution in the physiological pH range predominantly are present as monomers, usual additives and possibly a conventional insulin and possibly one or more adsorption promoting substances provide a fast absorption of the insulin activity administered.